HCV NS3 inhibitors (Tianjin Longwood Biopharmaceuticals)

N/A

Report date: 2025/01/26 19:08:06
NME

Base Information

Drug NameHCV NS3 inhibitors (Tianjin Longwood Biopharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus (HCV) nonstructural protein 3 inhibitors
TargetsHepatitis C virus (HCV) nonstructural protein 3
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Longwood Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Longwood Biopharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A